Form 4 for ELV Elevance Health
Accepted 2025-04-25 00:00:00 ET · period of report 2025-04-24 · accession 0001156039-25-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-25 | 2025-04-24 | ELV | Kaye Mark | EVP, CFO | S - Sale | $424.82 | -4,588 | 19.0K | -19% | -$1.95M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-24 | S | D | 4,588 | $424.82 | 18,977 | D | — | — | (F1) This transaction was executed in multiple trades, each at the same price of $424.82. |